\
&
Contact us
\
&
Contact us
This was 6 months ago
LocationOnline
ProgrammesThe ERA4Health Partnership organises a webinar on Responsible Research and Innovation (RRI) and the integration of cutting-edge technologies such as Artificial Intelligence into healthcare systems.
During the webinar, Dr. Michal Rosen-Zvi, Director of Health and Life Sciences at IBM Research, Chief Scientist of the Cleveland Clinic–IBM Discovery Accelerator, and Associate Professor of Computational Medicine at the Hebrew University of Jerusalem, will present the transformative potential of generative AI technologies in healthcare, from accelerating drug discovery to supporting clinical decision-making. She will also address the ethical and regulatory challenges posed by data bias and privacy, emphasizing the importance of developing fair, transparent, and accountable AI systems tailored for medical applications.
Please use this link to register for the event.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI Continent Deployment: Best use of technologies
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
